No takes yet. Share an insight, caveat, or question.
Quantitative analysis finds that cash flow, liquidity, and leverage explain 38.8% of financial distress in pharmaceutical firms, suggesting other factors at play.
Manangkabo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: